Clinical Trial Update: Clinical Trial With PRECIZON Presbyopic [NA]

View source ↗

Summary

The Ophtec BV-sponsored trial evaluating PRECIZON Presbyopic for cataract and presbyopia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Presbyopia

Drugs mentioned

• PRECIZON Presbyopic

Snippet

Sponsor: Ophtec BV | Conditions: Cataract, Presbyopia | NA | Status: COMPLETED